Ushiba D, Nakae T, Akiyama T, Kishimoto Y
J Bacteriol. 1966 May;91(5):1705-12. doi: 10.1128/jb.91.5.1705-1712.1966.
Daizo, Ushiba (Keio University School of Medicine, Tokyo, Japan), Taiji Nakae, Takehisa Akiyama, and Yoshio Kishimoto. Characterization of "clearance" factor and "cell-bound" antibody in experimental typhoid. J. Bacteriol. 91:1705-1712. 1966.-The "clearance" factor produced in the serum of rabbits immunized with a killed vaccine of an S-type virulent strain of Salmonella enteritidis was identified as O agglutinin and characterized immunochemically as a class of macroglobulin with a sedimentation coefficient of 12.7S. The macroglobulin, which was isolated by means of diethylaminoethyl cellulose column chromatography and sucrose density gradient centrifugation, showed a single protein peak when subjected to cellulose acetate electrophoresis and analytical ultracentrifugation. Its activity as agglutinin and "clearance" factor was inactivated both by mercaptoethanol treatment and absorbtion with the specific O antigen. The H agglutinin was also isolated as a single globulin fraction with relatively low molecular weight, and was characterized as a 7S gamma-globulin. This fraction had no "clearance" activity. A macroglobulin, similar to that identified in the rabbit serum, was extracted with urea from the cells of mice immunized with the S-type killed vaccine, but not from mice immunized with a live vaccine (R-type mutant), although this latter vaccine is very effective in producing a solid immunity against typhoid disease. The relation of this "cell-bound" antibody to the mechanism of "cellular" immunity in experimental typhoid is discussed.
大藏、牛场(日本东京庆应义塾大学医学院)、中江太极、秋山武久及岸本义雄。实验性伤寒中“清除”因子和“细胞结合”抗体的特性。《细菌学杂志》91:1705 - 1712,1966年。——用肠炎沙门氏菌S型强毒株死疫苗免疫的家兔血清中产生的“清除”因子被鉴定为O凝集素,免疫化学特性为一类沉降系数为12.7S的巨球蛋白。通过二乙氨基乙基纤维素柱层析和蔗糖密度梯度离心分离得到的巨球蛋白,经醋酸纤维素电泳和分析超速离心显示为单一蛋白峰。其作为凝集素和“清除”因子的活性经巯基乙醇处理和用特异性O抗原吸收后均被灭活。H凝集素也被分离为相对低分子量的单一球蛋白组分,特性为7Sγ球蛋白。该组分无“清除”活性。一种与在家兔血清中鉴定出的类似的巨球蛋白,能用尿素从小鼠细胞中提取,这些小鼠用S型死疫苗免疫,但不能从用活疫苗(R型突变株)免疫的小鼠中提取,尽管后一种疫苗在产生针对伤寒病的牢固免疫力方面非常有效。本文讨论了这种“细胞结合”抗体与实验性伤寒中“细胞”免疫机制的关系。